ERBB2 and metastatic malignant neoplasm in the lymph nodes: Furthermore, based on the optimal radiomic features and clinical risk factors (patient age, pathological grade, Ki-67, and lymph node metastasis), a clinical predictive nomogram for Her2+/Luminal molecular subtypes was constructed.